Halozyme (HALO) Stock Statistics & Valuation Metrics

Halozyme has a market cap or net worth of MXN 218.91B. The enterprise value is MXN 15.71B.

Market Cap

MXN 218.91B

Enterprise Value

MXN 15.71B

Halozyme has 114,010,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

114,010,000

Owned by Insiders

0.92%

Owned by Institutions

73.01%

Halozyme’s return on equity (ROE) is 6.49 and return on invested capital (ROIC) is 23.20%.

Return on Equity (ROE)

6.49

Return on Assets (ROA)

0.13

Return on Invested Capital (ROIC)

23.20%

Return on Capital Employed (ROCE)

0.34

Revenue Per Employee

3.30M

Profits Per Employee

749.15K

Employee Count

423

Asset Turnover

0.55

Inventory Turnover

1.30

The current PE Ratio of Halozyme is 24.50. Halozyme’s PEG ratio is -1.74.

PE Ratio

24.50

PS Ratio

6.48

PB Ratio

-212.02

Price to FCF

13.19

Price to Operating Cash Flow

13.04

PEG Ratio

-1.74

In the last 12 months, Halozyme had revenue of 1.40B and earned 316.89M in profits. Earnings per share was 2.64.

Revenue

1.40B

Gross Profit

1.17B

Operating Income

802.59M

Pretax Income

466.88M

Net Income

316.89M

EBITDA

573.05M

Earnings Per Share (EPS)

2.64

In the last 12 months, operating cash flow was 898.27M and capital expenditures -12.39M, giving a free cash flow of 885.88M billion.

Operating Cash Flow

898.27M

Free Cash Flow

885.88M

Free Cash Flow per Share

7.78

Halozyme pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

7.59%

Earnings Yield

4.15%

Beta

0.37

52-Week Price Change

85.88%

50-Day Moving Average

2013.78

200-Day Moving Average

1475.07

Relative Strength Index (RSI)

77.52

Average Volume (3m)

545

Halozyme upcoming earnings date is Feb 23, 2027, TBA (Not Confirmed).

Last Earnings Date

Nov 05, 2026

Next Earnings Date

Feb 23, 2027

Ex-Dividend Date

―

Halozyme as a current ratio of 4.66, with Debt / Equity ratio of 4389.38%

Current Ratio

4.66

Quick Ratio

3.66

Debt to Market Cap

0.27

Net Debt to EBITDA

3.51

Interest Coverage Ratio

44.28

In the past 12 months, Halozyme has paid 149.99M in taxes.

Income Tax

149.99M

Effective Tax Rate

0.32

Halozyme EV to EBITDA ratio is 17.25, with an EV/FCF ratio of 15.69.

EV to Sales

7.71

EV to EBITDA

17.25

EV to Free Cash Flow

15.69

EV to Operating Cash Flow

15.47

Halozyme has MXN 1.07B in cash and marketable securities with MXN 3.25B in debt, giving a net cash position of -MXN 2.18B billion.

Cash & Marketable Securities

MXN 1.07B

Total Debt

MXN 3.25B

Net Cash

-MXN 2.18B

Net Cash Per Share

-MXN 19.09

Tangible Book Value Per Share

-MXN 13.44

Gross margin is 82.27%, with operating margin of 55.91%, and net profit margin of 26.93%.

Gross Margin

82.27%

Operating Margin

55.91%

Pretax Margin

36.34%

Net Profit Margin

26.93%

EBITDA Margin

44.70%

EBIT Margin

37.56%

The average price target for Halozyme is MXN 2,219.53, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

MXN 2,219.53

Price Target Upside

6.35% Downside

Analyst Consensus

Moderate Buy

Analyst Count

6

Revenue Growth Forecast

30.42%

EPS Growth Forecast

-24.96%

Smart Score

8

AI Score

―